Like azathioprine, this drug may lower some blood cell counts, especially white blood cells. It's important that patients have their blood checked regularly and keep all clinic appointments. Many transplant patients have had healthy babies while taking anti-rejection drugs. CellCept, however, may be harmful to the unborn baby. Pregnancy and breastfeeding are not advised while taking this medication.
Tums are okay to use and have no effect on mycophenolate.
OKT3 OKT3 prevents rejection immediately after the transplant, and also treats acute rejection episodes. It is given intravenously for 7 to 14 days. Side effects may include flu-like symptoms with chills and fever, nausea and vomiting, headache, shortness of breath, chest tightness, and tremors. These drugs are similar to OKT3, and may be used after transplant to prevent rejection or to treat acute rejection episodes. They must be given intravenously, usually for 10-14 days.